Childhood cancers trials in Switzerland

In Switzerland 54 Also abroad 2459

54 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Where
Bellinzona, Lucerne
Age
12 years and over
People
840 worldwide
Run by
Nuvalent Inc.
See details and how to joinNCT05384626 · EU 2024-514266-39-00
Phase 4Taking people
Adjustment of Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Augmented Renal Clearance
Where
Lausanne
Age
61 days to 18 years
People
30
Run by
Centre Hospitalier Universitaire Vaudois
See details and how to joinNCT06293677
Phase 2/3Taking people
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Where
Bern
People
1,541 worldwide
Run by
Celgene
See details and how to joinNCT03435796 · EU 2023-504201-36-00
No phaseTaking people
PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan
Where
Basel
People
753
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07484269
Phase 3Taking people
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Where
Zurich
Age
1 year to 64 years
People
750 worldwide
Run by
Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00
No phaseTaking people
Swiss 2024 Continous Fever Monitoring in Pediatric Oncology Patients
Where
Bern
Age
1 month to 17 years
People
250
Run by
Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT05940766
Phase 2/3Taking people
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Where
Chur, Zurich
Age
18 years and over
People
740 worldwide
Run by
Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00
Phase 2Taking people
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Where
Bern, Lausanne, Zurich
Age
1 year to 17 years
People
100 worldwide
Run by
Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00
Phase 2Enrolling by invitation
Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
Where
Bellinzona
People
1,500 worldwide
Run by
Kite, A Gilead Company
See details and how to joinNCT05041309 · EU 2023-507041-28-00
Phase 2/3Taking people
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Where
Basel, Geneva, Zurich
Age
1 month to 18 years
People
1,800 worldwide
Run by
St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00
No phaseTaking people
Impact of Gonadotoxic Therapies on Fertility
Where
Bern
Age
14 years to 50 years
People
7,000
Run by
Michael von Wolff
See details and how to joinNCT05885048
No phaseTaking people
Swiss Childhood Cancer Survivor Study
Where
Bern
Age
5 years and over
People
4,136
Run by
University of Bern
See details and how to joinNCT03297034
Phase 2Taking people
Combination Therapy for the Treatment of Diffuse Midline Gliomas
Where
Zurich
Age
2 years to 39 years
People
360 worldwide
Run by
University of California, San Francisco
See details and how to joinNCT05009992 · EU 2023-507598-16-00
No phaseTaking people
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
Where
Aarau, Sankt Gallen, Zurich
Age
12 years and over
People
4,975 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT02834884
No phaseNot yet taking people in Switzerland
Stockholm3 Test Validation in Men on Active Surveillance in Switzerland (CHAS3 Trial)
Where
Bern
People
350
Run by
Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT07478536
Phase 1Taking people
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
Where
Zurich
Age
2 years to 21 years
People
208 worldwide
Run by
Sabine Mueller, MD, PhD
See details and how to joinNCT04732065 · EU 2025-521180-13-00
No phaseTaking people
Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment
Where
Basel, Geneva, Lausanne
Age
3 months to 18 years
People
100
Run by
Gumy-Pause Fabienne
See details and how to joinNCT03180918
No phaseTaking people
Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study
Where
Basel
People
600
Run by
University Hospital, Basel, Switzerland
See details and how to joinNCT07546695
No phaseTaking people
Early Pulmonary Dysfunction in Childhood Cancer Patients
Where
Basel, Bern, Geneva, Lausanne, Zurich
Age
4 years to 22 years
People
140
Run by
University Children's Hospital Basel
See details and how to joinNCT05427136
No phaseTaking people
A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children
Where
Aarau, Basel
Age
Up to 18 years
People
40
Run by
University Children's Hospital Basel
See details and how to joinNCT06861530
Phase 3Taking people
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Where
Aarau, Basel, Bellinzona, Bern, Geneva, Lausanne, Lucerne, Sankt Gallen, Zurich
Age
Up to 18 years
People
683 worldwide
Run by
University Hospital Muenster
See details and how to joinNCT04043494 · EU 2023-508101-24-00
No phaseTaking people
Questionnaire on Congenital Cancer Signs Through Self-Assessment
Where
Bern
Age
Up to 21 years
People
205
Run by
Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT07378423
Phase 3Taking people
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
Where
Lausanne, Zurich
People
510 worldwide
Run by
Jazz Pharmaceuticals
See details and how to joinNCT05580562 · EU 2022-502051-56-00
Phase 1/2Taking people
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Where
Basel, Bern, Zurich
Age
12 years and over
People
606 worldwide
Run by
Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555
No phaseTaking people
Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine Tumors and Unresectable Metastases: a Europe-wide Study
Where
Bern
People
3,200
Run by
Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT06787014